Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.

SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...

LARGE livestock farms in Scotland have fuelled another worrying rise in deadly ammonia emissions, The National can reveal ...

Seasonal ailments grip metropolis ...

For many RNLD’s in general practice, annual health checks are core to the care they offer. However, only just over a quarter ...

Delhi’s air quality has plunged to hazardous levels, with AQI readings crossing 400 in several areas. Doctors warn that the toxic air is not only harming the lungs but also damaging the heart, ...

Angina, a symptom of underlying heart disease, is frequently overlooked in women despite being a leading cause of death.

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating BRAFTOVI® (encorafenib ...

October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...